RE: Head of Communications17 Jun 2021 20:15
About us: Synairgen is a respiratory-focused pharmaceutical company preparing to launch SNG001 for the treatment of COVID in the US, UK & EU.
Further, when did me start referring to ourselves as a pharmaceutical company as apposed to a drug discovery company. Perhaps I've not noticed before, either way, its encouraging.